Transgene-Induced Chromosomal Rearrangement With Aberrant Human Vascular Endothelial Growth Factor at the Optic Fissure Leads to Uveal Coloboma in Mice
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.13.7 ↗At a glance
Beobachtungsstudie in Investigative Ophthalmology & Visual Science, 2025. Written by Yuhong Anna Wang and 15 co-authors. Institution: Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States. Major MEDLINE topics: Coloboma, Uvea, Vascular Endothelial Growth Factor A, Gene Rearrangement. 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Intramural NIH HHS.
Abstract (original language)
Purpose
The pathogenesis of uveal coloboma, a potentially blinding congenital ocular malformation, is incompletely understood. We characterize a novel mouse model of coloboma, Retinal and Iris Coloboma (RICO).
Methods
Transgenic mice were created by insertion of a human vascular endothelial growth factor-165 (hVEGF) gene driven by a neuron-specific enolase promoter. Mice were examined clinically and histologically, and the insertion site was characterized by fluorescence in situ hybridization and genomic sequencing. Gene expression changes were assessed with RNA sequencing, immunofluorescence, and in situ hybridization.
Results
RICO mice are viable in the homozygous state and exhibit fully penetrant autosomal semidominant coloboma. Coloboma is associated with persistence of periocular mesenchyme in the optic fissure, likely contingent on a specific, transgene insertion-induced genomic rearrangement on chromosome 13 that drives aberrant hVEGF expression. RICO eye cups exhibit altered expression of genes in the vicinity of the insertion site, where deletions of the human homologous locus were found in coloboma patients. RNA sequencing demonstrates changes in multiple coloboma-associated genes.
Conclusions
RICO represents a useful model for studying the pathogenesis of human coloboma.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
- NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States.
- University College London, London, United Kingdom.
- University of Michigan, Ann Arbor, Michigan, United States.
Funding
- Intramural NIH HHS
Cite
APA
Wang, Y. A., Alur, R. P., Kalaskar, V., George, A., Boobalan, E., McGaughey, D. M., Onojafe, F. I., Dutra, A., Pak, E., Thomas, J. W., Dong, L., Fruttiger, M., Pieke-Dahl, S., Guan, B., Hitchcock, P. F., & Brooks, B. P. (2025). Transgene-Induced Chromosomal Rearrangement With Aberrant Human Vascular Endothelial Growth Factor at the Optic Fissure Leads to Uveal Coloboma in Mice. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.13.7
Vancouver
Wang YA, Alur RP, Kalaskar V, George A, Boobalan E, McGaughey DM, et al. Transgene-Induced Chromosomal Rearrangement With Aberrant Human Vascular Endothelial Growth Factor at the Optic Fissure Leads to Uveal Coloboma in Mice. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.13.7
BibTeX
@article{Wang2025,
author = {Wang, Yuhong Anna and Alur, Ramakrishna P and Kalaskar, Vijay and George, Aman and Boobalan, Elangovan and McGaughey, David M and Onojafe, Felix I and Dutra, Amalia and Pak, Evgenia and Thomas, James W and Dong, Lijin and Fruttiger, Marcus and Pieke-Dahl, Sandra and Guan, Bin and Hitchcock, Peter F and Brooks, Brian P},
title = {Transgene-Induced Chromosomal Rearrangement With Aberrant Human Vascular Endothelial Growth Factor at the Optic Fissure Leads to Uveal Coloboma in Mice},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.13.7}
}
EUVIMED